FAF
Fjarde Ap-fonden’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.28M | Buy |
118,650
+31,100
| +36% | +$1.12M | 0.04% | 356 |
|
|
2025
Q1 | $2.73M | Sell |
87,550
-39,000
| -31% | -$1.21M | 0.03% | 407 |
|
|
2024
Q4 | $3.23M | Buy |
126,550
+41,300
| +48% | +$1.05M | 0.03% | 417 |
|
|
2024
Q3 | $2.41M | Buy |
+85,250
| New | +$2.41M | 0.02% | 454 |
|
|
2024
Q1 | $2.87M | Sell |
94,550
-19,300
| -17% | -$586K | 0.03% | 459 |
|
|
2023
Q4 | $3.2M | Buy |
113,850
+32,000
| +39% | +$899K | 0.04% | 436 |
|
|
2023
Q3 | $2.22M | Sell |
81,850
-7,100
| -8% | -$193K | 0.03% | 471 |
|
|
2023
Q2 | $2.73M | Sell |
88,950
-43,600
| -33% | -$1.34M | 0.03% | 446 |
|
|
2023
Q1 | $4.78M | Buy |
132,550
+29,350
| +28% | +$1.06M | 0.06% | 323 |
|
|
2022
Q4 | $4.08M | Sell |
103,200
-6,100
| -6% | -$241K | 0.06% | 341 |
|
|
2022
Q3 | $4.6M | Hold |
109,300
| – | – | 0.06% | 349 |
|
|
2022
Q2 | $4.6M | Sell |
109,300
-32,600
| -23% | -$1.37M | 0.06% | 349 |
|
|
2022
Q1 | $5.53M | Buy |
141,900
+21,400
| +18% | +$834K | 0.05% | 366 |
|
|
2021
Q4 | $4.8M | Buy |
120,500
+57,600
| +92% | +$2.3M | 0.04% | 408 |
|
|
2021
Q3 | $2.27M | Buy |
62,900
+700
| +1% | +$25.3K | 0.02% | 533 |
|
|
2021
Q2 | $2.55M | Sell |
62,200
-4,500
| -7% | -$184K | 0.02% | 532 |
|
|
2021
Q1 | $2.91M | Buy |
66,700
+24,300
| +57% | +$1.06M | 0.03% | 516 |
|
|
2020
Q4 | $2.12M | Buy |
+42,400
| New | +$2.12M | 0.02% | 540 |
|